Get the Stockscreener App
0.3862
3.43%
-0.0137
Evogene Ltd stock is traded at $0.3862, with a volume of 37,674.
It is down -3.43% in the last 24 hours and down -22.11% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
See More
Previous Close:
$0.3999
Open:
$0.41
24h Volume:
37,674
Relative Volume:
0.21
Market Cap:
$6.10M
Revenue:
$1.84M
Net Income/Loss:
$-17.51M
P/E Ratio:
-0.2789
EPS:
-1.3849
Net Cash Flow:
$-17.30M
1W Performance:
+1.05%
1M Performance:
-22.11%
6M Performance:
-51.43%
1Y Performance:
-69.83%
1-Day Range:
$0.3801
$0.41
1-Week Range:
$0.3701
$0.41
52-Week Range:
$0.3521
$1.35
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
0.3862 | 6.10M | 1.84M | -17.51M | -17.30M | -1.3849 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Weekly Recap: Board adds 2 and Pure withdraws offer, 60d standstill - TradingView
Form 13D/A Evogene Ltd. For: 11 October By Investing.com - Investing.com India
Form 13D/A Evogene Ltd. For: 11 October By Investing.com - Investing.com Canada
L.I.A. Pure Capital Submits 13D Amendment 7 Detailing Cooperation Agreement with Evogene Ltd. - Kalkine Media
Evogene reaches agreement with Pure Capital Group on board changes - Investing.com
Holders with 16.94% voting power strike a board deal with Evogene (EVGN). - Stock Titan
Holders of about 16.93% sign an Evogene (EVGN) deal that would reshape its board if approved. - Stock Titan
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors - PR Newswire
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors - Moomoo
Pure Capital nominees could fill four of Evogene's seven board seats. - Stock Titan
Form 4 Evogene Ltd. For: 30 September By Investing.com - Investing.com Nigeria
Form 4 Evogene Ltd. For: 30 September By Investing.com - Investing.com Nigeria
Evogene Ltd. SEC Filing (Sep 30, 2026) - stocktitan.net
Director receives 2,500 options with a $0.58 exercise price from Evogene (EVGN). - stocktitan.net
Evogene Director Nir Nimrodi Awarded 10,000 Stock Options Under 2021 Incentive Plan - Kalkine Media
10,000 options with a $0.58 exercise price go to Evogene (EVGN) director Nir Nimrodi. - stocktitan.net
A director receives 2,500 Evogene (EVGN) stock options with a $0.58 exercise price. - stocktitan.net
Evogene receives 180-day extension for Nasdaq compliance - Investing.com
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance - PR Newswire
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance - PR Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
After about $2M in seed sales a year earlier, first-half revenue fell at Evogene (EVGN). - stocktitan.net
All 3,384,616 shares were sold; Evogene (EVGN) moves to end their resale registration. - stocktitan.net
Two Evogene (EVGN) directors resign amid investor claims over AGM vote - Stock Titan
L.I.A. Pure Capital Intends to Commence a Special Tender Offer to Evogene - marketscreener.com
Investor group in Evogene (NASDAQ: EVGN) plans a special tender offer under Israeli law - Stock Titan
8.6% Evogene (EVGN) holder bought 1.26M shares in August - Stock Titan
Casterra announces $2.2 Mn of purchase orders to supply castor seeds - AgroSpectrum India
Evogene Confirms Board Slate at September 4 Shareholder Meeting - TipRanks
Evogene Ltd. Approves Board Appointments - marketscreener.com
Evogene (EVGN) sets seven-member board after 2026 shareholder vote - Stock Titan
Evogene stock trades lower as biotech investors eye latest pipeline moves - AD HOC NEWS
L.I.A. Pure Capital Acquires 19.35% Activist Stake in Evogene (NASDAQ: EVGN) - Kalkine Media
L.I.A. Pure Capital Takes 19.35% Activist Stake in Evogene (NASDAQ: EVGN), Pushes for Board Changes - kalkinemedia.com
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance Australia
Evogene urges shareholders to support current b... - pluang.com
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - TradingView
Evogene stock holds steady as investors eye latest genomics progress - ad-hoc-news.de
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - PR Newswire
Evogene (EVGN) investor group pushes for board seats at annual meeting - Stock Titan
[6-K] Evogene Ltd. Current Report (Foreign Issuer) - Stock Titan
Evogene Updates U.S. Investors With New August 2026 Presentation - TipRanks
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com India
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com Canada
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com UK
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees - PR Newswire
Evogene Ltd (EVGN) Stock News Today - tradingkey.com
Evogene (EVGN) Momentum: Ends Higher by 3.14% at $0.60 on the Day; Next Session: $0.57 and $0.63 Define the Nearby Reference Levels for the Current SessionMoney Flow - dars.gov.et
Evogene (EVGN) Momentum: Ends Higher by 3.14% at $0.60 on the Day; Next Session: $0.57 and $0.63 Define the Nearby Reference Levels for the Current SessionDay Trade Opportunities - vinanet.vn
Evogene Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Evogene Ltd Stock (EVGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RECANATI LEON | Director |
Aug 11 '26 |
Buy |
0.64 |
460,000 |
292,100 |
1,343,886 |
| RECANATI LEON | Director |
Aug 04 '26 |
Buy |
0.50 |
800,000 |
400,000 |
883,886 |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):